Jennison Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-65,449
Closed -$21.3M – 618
2024
Q1
$21.3M Sell
65,449
-35,102
-35% -$8.62M 0.01% 336
2023
Q4
$19.2M Buy
100,551
+11,651
+13% +$2.2M 0.01% 333
2023
Q3
$17.7M Buy
+88,900
New +$21M 0.02% 327
2023
Q2
– Sell
-4,168
Closed -$904K – 635
2023
Q1
$904K Sell
4,168
-76,924
-95% -$15M ﹤0.01% 505
2022
Q4
$16.7M Sell
81,092
-1,035
-1% -$262K 0.02% 342
2022
Q3
$22.8M Sell
82,127
-72,514
-47% -$18.4M 0.02% 307
2022
Q2
$29.6M Sell
154,641
-278,893
-64% -$49.2M 0.03% 253
2022
Q1
$89.9M Buy
433,534
+215,142
+99% +$35.5M 0.07% 132
2021
Q4
$38.9M Sell
218,392
-73,022
-25% -$14.4M 0.02% 265
2021
Q3
$60M Buy
291,414
+1,826
+0.6% +$359K 0.04% 186
2021
Q2
$54.9M Sell
289,588
-237,326
-45% -$38.8M 0.04% 212
2021
Q1
$68.6M Sell
526,914
-50,192
-9% -$6.02M 0.05% 175
2020
Q4
$59.9M Sell
577,106
-5,828
-1% -$505K 0.04% 178
2020
Q3
$44.2M Buy
582,934
+1,926
+0.3% +$109K 0.04% 204
2020
Q2
$27.5M Buy
581,008
+2,950
+0.5% +$122K 0.02% 248
2020
Q1
$19.2M Sell
578,058
-2,276
-0.4% -$90.4K 0.02% 260
2019
Q4
$25.5M Buy
580,334
+276,907
+91% +$10.2M 0.03% 278
2019
Q3
$9.08M Buy
303,427
+105,095
+53% +$4.46M 0.01% 412
2019
Q2
$11.3M Sell
198,332
-14,134
-7% -$686K 0.01% 421
2019
Q1
$7.11M Buy
+212,466
New +$7.06M 0.01% 452

Other funds holding SWAV

Jennison Associates's SWAV Position: Q2 2024 in Review

Jennison Associates sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 65,449 shares — an estimated $21.3M sold.

Jennison Associates first reported a position in SWAV in Q1 2019 and held it in 20 quarters. The position peaked at $89.9M in Q1 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Jennison Associates reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jennison Associates sold 65,449 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $21.3M.
  • Jennison Associates first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
  • Jennison Associates's Shockwave Medical, Inc. Common Stock position peaked at $89.9M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.